NCT02492841

Brief Summary

Background: Dental caries is considered an oral health problem worldwide. In Chile the last national epidemiological study (2007) showed a national prevalence of dental caries in children 6 years (70.3%) and 12 (62.5%). Direct pulp capping is a preventive dental therapy, keeps the vitality of the tooth using some inductive materials mineralized tissue formation. Objective: The main objective of this study is to evaluate the effectiveness of two innovative direct pulp capping materials; Biodentine compared MTA and calcium hydroxide in the maintenance of pulp vitality in teeth permanent molars.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
169

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Apr 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2014

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

May 27, 2015

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 9, 2015

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2016

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2016

Completed
1 year until next milestone

Results Posted

Study results publicly available

August 14, 2017

Completed
Last Updated

May 30, 2024

Status Verified

May 1, 2024

Enrollment Period

2 years

First QC Date

May 27, 2015

Results QC Date

May 1, 2017

Last Update Submit

May 6, 2024

Conditions

Keywords

dentin substitutevital pulp therapyBiodentinecaries

Outcome Measures

Primary Outcomes (1)

  • Parameters Evaluated After Treatment

    vitality test with electric device cold and hot test radiographic evaluation

    3 months, 6 moths and 12 months

Secondary Outcomes (1)

  • Number of Participants With Adverse Effects

    1 week, 3 and 6 months

Study Arms (3)

Mineral trioxide aggregate (MTA)

EXPERIMENTAL

Mineral trioxide aggregate Root canal repair material

Drug: Mineral trioxide aggregate

Calcium hydroxide

ACTIVE COMPARATOR

-material for pulp capping

Drug: Calcium hydroxide

Biodentine

EXPERIMENTAL

Is a calcium-silicate based materia root perforations, apexification, resorptive lesions, and retrograde filling material in endodontic surgery, pulp capping

Drug: Biodentine

Interventions

Mineral trioxide aggregate

Also known as: MTA Pro Root
Mineral trioxide aggregate (MTA)

Classic calcium hydroxide root canal repair material. Inorganic compound (CA(OH)2. It is the gold standard direct pulp cupping material.

Also known as: Calcium hydroxide Hertz
Calcium hydroxide

Biodentine (trademark). Septodont. Biodentine root canal repair material. A predose capsule plus five drops of calcium chloride solution.

Also known as: Active biosilicate. Septodont.
Biodentine

Eligibility Criteria

Age7 Years - 16 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Systemically healthy patients
  • Patients with at least one full or partial tooth root development
  • Clinical examination of the tooth must be selected diagnostic tests that are consistent with reversible pulpitis
  • Radiographic examination should show images of normal tissues without signs of internal resorption, the remaining healthy coronary should be sufficient for an indication of direct restoration
  • Teeth that have pulp exposure not exceeding 1 mm in size.

You may not qualify if:

  • Every child with systemic and / or neurological conditions that make it impossible to focus on conventional dental clinic
  • Teeth uncontrolled excessive bleeding during communication pulp those aiming or have plans to move during that time period of 8 months .

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro de Salud de San Bernardo Universidad de Los Andes

Santiago, Chile

Location

Related Publications (3)

  • Paranjpe A, Zhang H, Johnson JD. Effects of mineral trioxide aggregate on human dental pulp cells after pulp-capping procedures. J Endod. 2010 Jun;36(6):1042-7. doi: 10.1016/j.joen.2010.02.013. Epub 2010 Mar 15.

    PMID: 20478462BACKGROUND
  • Leye Benoist F, Gaye Ndiaye F, Kane AW, Benoist HM, Farge P. Evaluation of mineral trioxide aggregate (MTA) versus calcium hydroxide cement (Dycal((R)) ) in the formation of a dentine bridge: a randomised controlled trial. Int Dent J. 2012 Feb;62(1):33-9. doi: 10.1111/j.1875-595X.2011.00084.x.

    PMID: 22251035BACKGROUND
  • Nowicka A, Lipski M, Parafiniuk M, Sporniak-Tutak K, Lichota D, Kosierkiewicz A, Kaczmarek W, Buczkowska-Radlinska J. Response of human dental pulp capped with biodentine and mineral trioxide aggregate. J Endod. 2013 Jun;39(6):743-7. doi: 10.1016/j.joen.2013.01.005. Epub 2013 Apr 10.

    PMID: 23683272BACKGROUND

MeSH Terms

Conditions

Dental Pulp Exposure

Interventions

mineral trioxide aggregateCalcium Hydroxidetricalcium silicate

Condition Hierarchy (Ancestors)

Dental Pulp DiseasesTooth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

HydroxidesAlkaliesInorganic ChemicalsCalcium CompoundsAnionsIonsElectrolytes

Limitations and Caveats

The small sample due to inclusion criteria. Lack of collaboration from the primary health providers. And the fact that the oral health seems not to be a priority and people only come when it hurts and it is too late for prevention.

Results Point of Contact

Title
Dra. CLAUDIA BRIZUELA CORDERO
Organization
UNIVERSIDAD DE LOS ANDES

Study Officials

  • Claudia Brizuela

    Universidad de Los Andes

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
DDS

Study Record Dates

First Submitted

May 27, 2015

First Posted

July 9, 2015

Study Start

April 1, 2014

Primary Completion

April 1, 2016

Study Completion

August 1, 2016

Last Updated

May 30, 2024

Results First Posted

August 14, 2017

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations